Monthly buprenorphine injections from a mobile pharmacy clinic
About this title
Read the official source — NCT07176351Understand this study
Who could participate?
Listed age limits: from 18 years.
What will I do during this study?
This six-month prospective study takes place through a mobile pharmacy clinic. Participants discuss options with a clinician and can choose whether to start weekly or monthly extended-release buprenorphine injections; dosing is based on medical need. The study collects medical-visit and medical-record data during follow-up.
- Listed locations
- New HavenSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 60
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT07176351
- Official title
Show the full official title
Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic: A Pilot Study
Recruitment & locations
New Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Does this study involve medication?
Yes. The study involves medication, including Buprenorphine.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
